Postmarketing Observational Study Of The Impact Of Prevnar 13 (Pneumococcal 13 Valent Conjugate Vaccine) On Otitis Media In Children.
Phase of Trial: Phase IV
Latest Information Update: 30 Sep 2014
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- Sponsors Pfizer
- 30 Sep 2014 Planned number of patients changed from 0 to 391 as reported by ClinicalTrials.gov record.
- 14 Apr 2014 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 14 Feb 2014 According to the ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.